Raymond James Financial’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$456M Sell
5,023,587
-240,674
-5% -$22M 0.12% 134
2026
Q1
$540M Sell
5,264,261
-142,301
-3% -$16.1M 0.17% 103
2025
Q4
$678M Sell
5,406,562
-129,616
-2% -$16.5M 0.21% 86
2025
Q3
$742M Buy
5,536,178
+107,843
+2% +$14.2M 0.24% 73
2025
Q2
$738M Sell
5,428,335
-68,021
-1% -$8.97M 0.25% 68
2025
Q1
$729M Sell
5,496,356
-118,142
-2% -$15M 0.27% 67
2024
Q4
$635M Buy
+5,614,498
New +$649M 0.23% 68

Other funds holding ABT

Raymond James Financial's ABT Position: Q2 2026 in Review

Raymond James Financial reduced its Abbott (ABT) stake by 4.6% in Q2 2026, selling an estimated $22M and leaving 5,023,587 shares worth $456M. The position accounts for 0.12% of the portfolio, ranked #134.

Raymond James Financial first reported a position in ABT in Q4 2024 and has held it in 7 quarters since. The position peaked at $742M in Q3 2025. 2,982 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Raymond James Financial held 5,023,587 shares of Abbott worth $456M as of Q2 2026.
  • Raymond James Financial sold 240,674 Abbott shares in Q2 2026, an estimated $22M.
  • Abbott made up 0.12% of Raymond James Financial's portfolio in Q2 2026, its #134 holding.
  • Raymond James Financial first reported a position in Abbott in Q4 2024 and has held it in 7 quarters since.
  • Raymond James Financial's Abbott position peaked at $742M in Q3 2025.
  • 2,982 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.